Home›People›Michael Banville
Michael Banville

Michael Banville

CEO and President at ALZpath.

Executive
Updated Nov 10, 2026·Latest SEC filing Jul 21, 2026·Suggest an edit

About Michael Banville

Michael Banville is CEO and President at ALZpath.

Experience

This experience comes from Michael Banville's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Banville in the role, so the role may have started earlier or lasted longer.

ALZpath, Inc. Current
CEO and President
Chief Executive Officer (2025 – Present)
2025 – Present · Carlsbad, CA
Licenses an antibody to diagnostic companies for use in Alzheimer's blood tests.
Game Plan
Chief Executive Officer
2023 – 2024
Sensable Health
Chief Executive Officer
2022 – 2023
SSB
Chief Executive Officer
2018 – 2021
IHS Markit | Technology
Vice President - Global Offshoring Strategy (2012 – 2017)
Vice President, Strategic Marketing, Americas (2007 – 2012)
2007 – 2017
Cambridge Energy Research Associates
Senior Director, Business Development (2001-2007), Director, Marketing (1996-2000)
1996 – 2007

Key Colleagues at Startups

The people Michael Banville works with at each company, as listed on that company's latest Form D.

ALZpath, Inc. · Form D, Jul 21, 2026
Harry Johns
Harry Johns
Director
John Hensing
John Hensing
Director
Irit Rappley
Irit Rappley
Director
Jerre Stead
Jerre Stead
Co-Founder, Chair

Sources

  1. SECALZpath, Inc. Form D, filed Jul 21, 2026